lysine has been researched along with Cortical Lewy Body Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adame, A; Campioni, S; Gage, FH; Gerez, J; Jensen, PH; Mante, M; Masliah, E; Nuber, S; Overk, CR; Patrick, C; Picotti, P; Riek, R; Rockenstein, E; Trejo-Morales, M; Ubhi, K; Winkler, J; Winner, B | 1 |
| Dalfó, E; Ferrer, I | 1 |
2 other study(ies) available for lysine and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Topics: alpha-Synuclein; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Gene Expression Regulation; Glutamic Acid; Humans; Lewy Body Disease; Lysine; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Synapses; Thy-1 Antigens | 2014 |
Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Female; Humans; Immunoprecipitation; Lewy Body Disease; Lysine; Male; Middle Aged; Neocortex; Oxidation-Reduction; Parkinson Disease | 2008 |